Fludeoxyglucose F 18 Injection, Solution
Product Images NDC 60055-334

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F 18 (NDC 60055-334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Draximage Inc., Dba Jubilant Radiopharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fludeoxyglucose F 18 Injection

This text provides details about a diagnostic injection called Fludeoxyglucose F 18. The injection comes in a multiple-dose vial with an activity range of 20 mCi/mL to 300 mCi/mL with a total volume of __mL. The injection is sterile, non-pyrogenic, and should only be used intravenously. The injection contains Fludeoryglucose F18, stabilized with 0.05% to 0.5% v ethanol. The injection must not be used if it appears cloudy, or it contains particulate matter. The injection has an End of Synthesis of 12 hours, after which it must not be used. The injection must be stored at 25°C (77°F) in a shielded container and must be withdrawn and handled using aseptic techniques. The manufacturer of this diagnostic injection is Jubilant Radiopharma located in Yardley, PA. A prescription is needed to use this diagnostic injection.*

FDA Label Image

Image Description (Fludeoxyglucose 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.